Bal Pharma (BOM:524824) 3-Year EBITDA Growth Rate : 10.50% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Bal Pharma 3-Year EBITDA Growth Rate?

Bal Pharma's EBITDA per Share for the three months ended in Mar. 2024 was ₹9.81.

During the past 12 months, Bal Pharma's average EBITDA Per Share Growth Rate was 34.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 26.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bal Pharma was 70.20% per year. The lowest was -32.50% per year. And the median was 7.90% per year.

Competitive Comparison of Bal Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bal Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bal Pharma's 3-Year EBITDA Growth Rate falls into.

Bal Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bal Pharma (BOM:524824) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bal Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bal Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bal Pharma (BOM:524824) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (BOM:524824) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

BALPHARMA:India

Address

10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052

Website

https://www.balpharma.com

Bal Pharma Ltd is a pharmaceutical company. Principally, it is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives. It offers products in dosage forms, such as tablets, capsules, syrups, suspensions, creams, and ointments to various markets. The company caters to both domestic and international markets, of which key revenue is derived from Outside India.

Bal Pharma (BOM:524824) Headlines

No Headlines